Related Experiment Video
Updated: Feb 1, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
Tumor Location Significantly Correlates With PD-L1 Status in Patients With Small Sized Non-small Cell Lung Cancer
Takuma Tsukioka1, Ryu Nakajima2, Kyukwang Chung2
1Department of General Thoracic Surgery, Osaka City General Hospital, Osaka, Japan t-tukioka@med.osakacity-ho.or.jp.
Background/Aim:
Predicting programmed death-ligand 1 (PD-L1) expression in resectable lung cancer cases is highly significant for establishing treatment strategies. Although there were differences in tumor characteristics between central and peripheral lesions in non-small cell lung cancer (NSCLC), the relationship between tumor location and PD-L1 expression status has not been examined. We investigated the relationship between clinical background factors, including tumor location, and PD-L1 expression status.
Patients And Methods:
A total of 245 NSCLC patients whose tumors were measuring 3 cm or less in diameter and had a consolidation tumor ratio (CTR) <0.5 were included in this study. A tumor was classified as peripheral if its location was in the outer one-third of the computed tomography horizontal section, and as central otherwise. PD-L1 immunohistochemistry was performed using 22C3 antibody. PD-L1 expression status were categorized as negative [PD-L1 tumor proportion score (TPS) <1%] and as positive (PD-L1 TPS ≥1%).
Results:
Statistically significant differences were identified in CTR (p=0.006), histology type (p<0.001) and tumor location (p=0.036) according to the PD-L1 expression status. A greater proportion of patients with a smoking history were observed in the PD-L1 expression positive group (p=0.076). Multivariate analysis revealed 0.94< CTR (p=0.033), non-adenocarcinoma (p=0.018) and central lesion (p=0.034) were independent predictive factors for positive PD-L1 expression status. A predictive scoring system incorporating these three factors demonstrated a stepwise increase in PD-L1 positivity with higher scores.
Conclusion:
PD-L1 expression status significantly correlated with CTR, histological type and tumor location. This is the first report demonstrating a significant correlation between PD-L1 expression and tumor location in NSCLC. We believe that differences in the cancer microenvironment based on tumor location influence PD-L1 expression status in cancer cells.
More Related Videos
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
Related Concept Videos
Cell Size
Surface Area
Cells can take in nutrients and water via diffusion through the plasma membrane itself or through specific channels in the membrane. The area of the membrane surrounding...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Correlation and Causation
Correlation versus Causation
If the dependent variable increases or decreases when the independent variable increases, there is a positive or negative...
Correlations
Lung Capacity
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...